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Abstract
Intuitively, keeping ones distance from a source of infection would appear to be the best way to limit the occurrence of
disease. However, this overlooks the importance of repeated infections in maintaining efficient immune defenses. When
acquired immunity has partly waned, re-exposure to the pathogenic agent may lead to mild disease that boosts the
immune system. This prevents the total loss of immunity that would lead to classical disease in cases of re-infection. Here,
using a mathematical model, we show that avoiding the pathogenic agent is detrimental in some situations, e.g. for
pathogens that are highly transmissible, are not excessively lethal and that induce rapidly waning immunity. Reducing
exposure to pathogenic agents is among the objectives of most, if not all, public health measures. A better understanding
of the factors influencing the severity of a disease is required before applying measures that reduce the circulation of
pathogenic agents.
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Introduction
Throughout history, people have fled from sources of infection
in an effort to prevent themselves from contracting disease. The
enforced isolation of lepers and tuberculosis sufferers and the
abandonment of villages infected with Black Death are classic
examples of this behaviour. Even today, who among us does not
flinch when someone sneezes or coughs beside us?
Theoretically, limiting exposure to pathogens, e.g. by avoiding
contact with sick people, should reduce disease occurrence.
Implicitly, this assumes that successful attacks by pathogens are
always deleterious for the host. But this assumption does not
always hold true. For example, the frequency of infections by
VZV, the virus responsible for Varicella and Zoster (when the
virus naturally reactivates after a latency period), is inversely
correlated with the occurrence of Zoster in elderly people [1]. In
this case, frequent exposure to the virus boosts the immune system
without causing harm and prevents the reactivation of the virus.
Similarly, immunity acquired after vaccination [2–5], but also
after natural infection [3,6], wanes with time and frequent natural
and attenuated re-infections help retain efficient immune defenses
[7–11]. In these contexts, avoidance of the infectious agent is not
always beneficial.
In a previous modelling framework, Aguas et al. [11] illustrated
this concept with a mathematical model of pertussis. They argued
for the existence of a re-infection threshold [12] above which mild
re-infections are frequent and immunity is boosted before waning.
Above the threshold, a reduction in the transmission rate of the
disease prevented natural boosting of the immune system and,
consequently, an increase in the number of severe cases was
apparent. This increase in the number of severe cases was
coincident with a huge increase in the number of mild infections:
an increase in the transmission rate of the disease by around 60%
led to a decrease of 20% in cases of severe disease, and a ten-fold
increase in the number of mild infections. Even if by definition
mild infections cause little harm to their host, one should
remember that what Aguas et al. [11] termed a mild infection
was in fact an infection that occurred during the period of partial
immune protection. While these infections are generally mild, they
can sometimes display severe symptoms, e.g. in malnourished or
immuno-compromised individuals. Similar results have recently
been obtained with a model representing the spread of Malaria
[13], a disease for which regular re-infections help to maintain an
efficient immune response [10]. The model was compared with
clinical data and explained the observed peaks in malaria hospital
admissions in children of less than 10 years of age at intermediate
transmission rates [14,15].
In the present paper, we explore the conditions under which
avoidance of exposure to the pathogen is detrimental to the host.
Waning immunity in the absence of natural boosting is a common
phenomenon that may apply to many host-pathogen interactions.
Empirical analyses of the durations of immunity and rates of
boosting are complex. As an alternative, here we develop a
mathematical model to determine the types of diseases for which
reducing the transmission rate of the pathogen could lead to the
most pronounced adverse effects. Considering individuals with a
given rate of exposure to a given pathogen, is it beneficial for them
to decrease this rate of exposure? The model helps to define the
characteristics of diseases for which classical health measures,
which consist of reducing peoples’ exposure to pathogenic agents,
could fail and even worsen the impact of the pathogenic agent.
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The mathematical model
Model with constant exposure rate. In the model we
assume that each individual follows one of the two following
strategies. Firstly, one can try to reduce their level of exposure to
the pathogen, for example by avoiding contact with sick people.
We define individuals that follow this strategy as ‘‘avoiders’’.
Secondly, one may take no special precautions to avoid infections
and allow the pathogenic agent to infect them normally. Here, we
refer to these individuals as ‘‘normal’’. ‘‘Avoiders’’ are less often
infected compared to ‘‘normal’’ individuals, but cannot avoid all
infections. We denote w as the relative rate at which ‘‘avoiders’’
become infected compared to ‘‘normal’’ individuals.
To investigate the effect of different levels of infection rate and
the duration of immunity on the benefit of avoiding exposure to
pathogens, we modified the classical susceptible-infected-recovered
(SIR) model to integrate different levels of acquired immunity and
the boosting effect of attenuated re-infections when it occurs
before the level of immunity falls below the protective threshold.
We add one class to the classical SIR model (Fig. 1) representing
mildly infected individuals (IM). We also split the R class into two:
newly recovered individuals (RN) that are fully protected against re-
infection; and formerly recovered individuals (RF) that can become
re-infected and develop the mild form of the disease. Individuals
are susceptible at birth, then become infected and develop the
classical form of the disease. Subsequent re-infections are
attenuated when they occur in the RF class and lead to a level of
immunity as high as that following classical infection (note that this
assumption does not modify the main results of the model).
Without attenuated infection, individuals lose their immune
defense and become fully susceptible.
As a first step we assume a constant rate of infection by the
pathogenic agent for each individual. The purpose here is not to
understand how the infection rate evolves with pathogen
circulation, but only to determine the best strategy for one
individual suffering a given (and constant) pathogen exposure.
Individuals that choose the ‘‘normal’’ strategy get infected with a
constant rate l. ‘‘Avoiders’’ get infected with a lower rate wl,
where w is a constant (w,1) that describes how avoidance of the
pathogenic agent reduces the frequency of infections. RF
individuals can become mildly infected at a rate q times
(0,q#1) that of the susceptible individuals having the same
behaviour. We assume a constant influx of births (b) and a constant
natural (i.e. from any cause other than the pathogen) death rate
(m). Classically and mildly infected individuals recover from the
disease at rates s and sM respectively, and die from the disease at
rates a and aM respectively. We call CM and CMM the case
mortalities, i.e. the probability that infected individuals die from
the infection instead of recovering, for the severe and the mild
infections, respectively (CM=a/[a+s] and CMM=aM/[aM+sM]).
Newly and formerly recovered individuals lose their protection at a
rate wN and wF respectively.
The model is described by the set of equations (by setting w=1:
we obtain the model for ‘‘normal’’ individuals. w,1: corresponds
to ‘‘avoiders’’):
dS
dt
~bzwFRF{mS{wlS
dI
dt
~wlS{ mzsza ðÞ I
dIM
dt
~qwlRF{ mzsMzaM ðÞ IM
dRN
dt
~sIzsMIM{ mzwN ðÞ RN
dRF
dt
~wNRN{ mzwF ðÞ RF{qwlRF
The set of assumptions we have made has allowed us to produce
a linear, and therefore simple, mathematical model. From a
biological point of view this means that in our model each
individual is not affected by the infectious status of other
individuals. This implies that we can run the model initially with
only ‘‘normal’’ individuals, and then only with ‘‘avoiders’’ and
compare how the different strategies alter the impact of the
pathogens. Results would be exactly the same if we assume a
mixed population with both ‘‘avoiders’’ and ‘‘normal’’ individuals.
Another interesting implication of the linearity of the model is that
t h er a t eo fi n f l u xo fn e w b o r n s( b), and thus the host population size,
will not have any effect on the results of the model presented here.
Model where exposure depends on infected
individuals. In the previous section we assumed that the rate
of infection of individuals is constant in the population. In fact, for
transmissible diseases, the number of infected individuals in the
host population will affect the rate of infection of susceptible
Figure 1. Flow diagram of the five classes of the modified SIR model. Arrows represent the transitions, with their associated rates. Transition
rates in red are the only ones that differ between ‘‘avoiders’’ and ‘‘normal’’ individuals.
doi:10.1371/journal.pone.0002299.g001
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infections, the rate of infection of susceptible individuals will be
reduced, which can have important consequences on whether or
not avoiding infections is a good strategy. To determine the
consequences of mass avoidance of infectious agents it is important
to incorporate the effect of avoidance on the rate of infection.
This model is similar to that from the previous section, except
that now the rate of infection depends on the number of infected
individuals. The proportion of individuals avoiding the infection is
then a critical factor, so we can no longer assume that the two
strategies are independent. Each class X is divided into two
subclasses, X
N and X
A, which represent the number of individuals
in class X following the ‘‘normal’’ and ‘‘avoider’’ strategies,
respectively. The model then reads:
l~b INzrIN
MzwIAzrwIN
A
  
dSN
dt
~ 1{pA ðÞ bzwFRN
F {mSN{lSN
dIN
dt
~lSN{ mzsza ðÞ IN
dIN
M
dt
~qlRN
F { mzsMzaM ðÞ IN
M
dRN
N
dt
~sINzsMIN
M{ mzwN ðÞ RN
N
dRN
F
dt
~wNRN
N{ mzwF ðÞ RN
F {qlRN
F
dSA
dt
~pAbzwFRA
F{mSA{wlSA
dIA
dt
~wlSA{ mzsza ðÞ IA
dIA
M
dt
~qwlRA
F{ mzsMzaM ðÞ IA
M
dRA
N
dt
~sIAzsMIA
M{ mzwN ðÞ RA
N
dRA
F
dt
~wNRA
N{ mzwF ðÞ RA
F{qwlRA
F
where b is the transmission rate of the pathogen from severely
infected ‘‘normal’’ individuals to susceptible ‘‘normal’’ individuals
and r is the relative rate at which mildly infected individuals
transmit the pathogen compared to severely infected ones. To
simplify, we assume that ‘‘avoiders’’ are w times less exposed (w,1)
than ‘‘normal’’ individuals. We also assume that when they are
sick, ‘‘avoiders’’ avoid transmitting the pathogen to other
individuals and are thus w times less infectious than ‘‘normal’’
individuals. Furthermore, we assume that mildly infected individ-
uals can also be avoided and, in turn, can avoid transmitting the
pathogen with the same success as severely infected individuals.
The reality is more complex, since in some cases mild infection
may be hard to detect, whereas in other circumstances mild
symptoms, such as coughing or sneezing, can be easily detected.
For our analysis, this assumption has only a slight qualitative
impact on the results presented in this paper.
Note the basic reproductive number for the pathogen in this
model is:
R0~
bK 1{pAzw
2pA
hi
mzazs
where K=b/m is the carrying capacity of the host population, i.e.
the size of the host population without pathogen. Note that in this
case a population consisting only of ‘‘avoiders’’ (pA=1) has a
R0 RA
0 ~
bKw
2
mzazs
 !
that is w
2 that of the R0 of a population
comprised exclusively of ‘‘normal’’ individuals (pA=0,
RN
0 ~
bK
mzazs
).
Parameters. The model is parameterized to represent a
typical European or North American human population.
Individuals have a 75-year life expectancy (m=1/75, the time
unit is years). Both forms of the disease (classical and attenuated)
last, on average, two weeks (a+s=aM+sM=24). Beyond reducing
the severity of the disease, partial immunity also reduces by a
factor of ten the probability of becoming infected (q=0.1). In the
model with constant exposure rate, ‘‘avoiders’’ are 10 times less
often infected than ‘‘normal’’ individuals (w=0.1); whereas in the
model where the exposure rate depends on infected individuals,
we assume that a population made up only of ‘‘avoiders’’ have a
basic reproductive number that is 10 times lower than that of a
population exclusively composed of ‘‘normal’’ individuals
(w~
ﬃﬃﬃﬃﬃﬃﬃ
0:1
p
~0:3162). To simplify, we assume that the two phases
of immunity, corresponding to full and partial protection, last on
overage the same duration, which is 6 months as a basic value
(wR=wF=2, if not allowed to vary). The rates l and b that
describe the force of infection of the pathogen in the models are
variable in all the situations tested and so have no basic value.
In the first part of the analysis of the model with constant
exposure and in the analysis of the model where the infection rate
depends on infected individuals, we consider a pathogen that does
not induce additional mortality on infected hosts (a=aM=0,
Fig. 2, 4 and 5). In the second part of the analysis of the model
with constant exposure (Fig. 3), we consider the case of lethal
pathogens, firstly only in their severe form (a.0, aM=0, Fig. 3A,
B) and then in both severe and mild forms (a.aM.0, Fig. 3C). It
might seem surprising to assume additional mortality associated
with mild infections. In fact, what we term a mild infection in our
models is an infection acquired during a period of partial
immunity. We use the term ‘mild infection’ because this kind of
infection is generally mild. But these infections can also become
severe (e.g. in individuals under stress), so it is natural to assume
that these ‘mild infections’ may also increase the risk of death for
individuals.
Results
Model with constant exposure rate
a) the case of non-lethal pathogens. First we focus on non-
lethal infections (Fig. 2). In this case we look at the increase in
disease frequency with pathogen avoidance, which is defined by
the ratio of the frequency at which ‘‘avoiders’’ get infected
compared to ‘‘normal’’ individuals. Note that an increase in
Risks of Avoiding Infections
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pathogen is in fact a beneficial strategy.
At a low infection rate, trying to avoid the infection is beneficial
(Fig. 2A). In particular, it reduces the risk of developing the
primary infection, whose severity cannot be reduced by the naı ¨ve
immune system. In cases where the infection rate is very low,
‘‘avoiders’’ always contract classical disease ten times less
frequently than ‘‘normal’’ individuals.
When the infection rate is high, a different scenario arises (see
Fig. 2A). The primary infection occurs sooner or later, but
‘‘normal’’ individuals boost their immunity rapidly following the
loss of their full immunity. So, they have little risk of developing
the classical disease more than once in their lifetime. In contrast,
avoiding infections increases the probability of losing partial
disease protection, thereby increasing the risk of repeated
development of the classical disease. However, at very high
infection rates, even ‘‘avoiders’’ have little chance of losing partial
disease protection and so the detrimental effect of avoiding the
pathogen is less evident.
Another important parameter of the model is the total duration
of acquired immunity (w{1
N zw{1
F ~2w{1
N since we always have
wN=wF) (Fig. 2B, C). The loss of partial immunity makes all
individuals, and more especially ‘‘avoiders’’, susceptible to
repeated classical disease occurrences. Clearly, a longer immune
period will reduce the number of secondary classical disease cases.
With life-long immunity, secondary infections never occur and
avoiding the pathogen is never a detrimental strategy (see Fig. 2B).
b) the case of lethal pathogens. Results for lethal pathogens
are similar to those for non-lethal pathogens described above. But
now we look at the decrease in life expectancy due to an avoidance
strategy. Note that a negative decrease means that avoidance is in
fact beneficial. Even for highly lethal pathogens, avoiding the
pathogenic agent is always detrimental when infection rates are
high. In fact, this detrimental effect becomes very small and occurs
only for very high infection rates as soon as the case mortality is
high (see for example Fig. 3A and CM=0.5, red line). A longer
immune period mitigates the detrimental effects of avoidance for
pathogens with low case mortality (Fig. 3B).
The detrimental effect of pathogen avoidance remains true even
when we assume additional mortality during mild infections
(Fig. 3C), as long as the case mortality of the mild disease remains
low (here below 5%). For example, with 1% case mortality for the
mild disease, avoiding the pathogenic agent may reduce the life
expectancy of individuals by 10 years.
Finally, it is important to note that in every case studied here
(see Fig. 2 and Fig. 3), avoiding infections is always a good strategy
when the infection rate is low.
Model where exposure depends on infected
individuals. Now we explore the problem from a population
perspective. We consider a population consisting of both
‘‘avoiders’’ and ‘‘normal’’ individuals (with a proportion pA of
‘‘avoiders’’) and assume that the rate of infection of susceptible
individuals depends on the number of each type of infected
individuals (i.e. mildly infected and severely infected individuals).
Figure 2. Detrimental effect of pathogen avoidance for non-lethal diseases. It is represented by the relative frequency (r, Y-axis) at which
‘‘avoider’’ individuals suffer classical infections compared to ‘‘normal’’ ones (when values are below one, avoiding the pathogenic agent is beneficial),
according to the rate of infection by a pathogenic agent (X-axis). (A) For total immune periods of one year, avoiding the pathogenic agent is
beneficial only for low infection rates. For high infection rates, both strategies tend to become equivalent since boosts to the immune system are
almost systematic; (B) for lifelong immunity, avoiding the pathogenic agent is always a good strategy; and (C) considering a continuum in the total
duration of immunity (in years) shows that ‘‘avoiders’’ can be more than six times more at risk of becoming sick compared to ‘‘normal’’ individuals.
The threshold where both strategies are equivalent (r=1) is represented with a dashed line (A) or with a bold red line (C).
doi:10.1371/journal.pone.0002299.g002
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‘‘avoiders’’ (pA) on the impact of the disease. The idea is to simulate
a public health measure and to determine which proportion of the
population should avoid the infection to make the impact of the
disease as low as possible. For the sake of simplicity, we assume no
disease-induced mortality such that the impact of the disease is,
here, related to the total number of infected individuals in the
population.
We look at the disease frequency in the population at
equilibrium as a function of the proportion of ‘‘avoiders’’ (pA) for
different values of the basic reproductive number (RN
0 ) of the
pathogen in a population consisting only of ‘‘normal’’ individuals
(Fig. 4). In the following paragraphs the term ‘‘basic reproductive
number of normal individuals’’ will be used to refer to RN
0 .
We identify four regimes, depending on different parameter
settings. In the first regime (Fig. 4A, regime A), the disease
frequency at equilibrium is a decreasing function of the proportion
of ‘‘avoiders’’ (pA). In this case the rate of infection is always too
low for the ‘‘normal’’ strategy to be efficient. Avoiding infections is
good for ‘‘avoiders’’, but also for the population. If the proportion
of individuals is such that the basic reproductive number of the
pathogen is decreased below 1, then the pathogen goes extinct
from the population. In the second regime (Fig. 4B, regime A-n),
avoiding the infection can be beneficial, but only if a sufficient
number of individuals in the population are ‘‘avoiders’’. If only a
small proportion of individuals avoid the infection, then the impact
of the disease can be increased by increasing the number of
‘‘avoiders’’. In contrast, for the third regime (Fig. 4C, regime N-a)
the ‘‘normal’’ strategy is the best one, but if most of the individuals
in the population are ‘‘avoiders’’ then increasing the proportion of
‘‘normal’’ individuals is deleterious. In the last regime (Fig. 4D,
regime N), the number of infected individuals at equilibrium is an
increasing function of the proportion of avoiders (pA). Even with all
individuals avoiding the infection, the rate of infection cannot fall
below the threshold where avoiding the infection becomes an
efficient strategy, and so avoiding the infection is always
deleterious. Note that in all regimes the best strategy is always
an extreme one (pA=0orpA=1).
Next, we investigate the effects of the basic reproductive
number of ‘‘normal’’ individuals (RN
0 ) and of the total duration of
immunity (w{1
N zw{1
F ~2w{1
N since wN=wF) (Fig. 5A). We look at
the regime in which the system attains equilibrium. We find that
for the smallest values of RN
0 the system always follows the first
regime (regime A), where avoiding infections is the best strategy
and always reduces the impact of the pathogen. With increasing
RN
0 the system follows the second regime (regime A-n), where
avoiding infection is still the best strategy, but can be detrimental if
not enough individuals in the population are ‘‘avoiders’’. Above a
threshold (bold line in Fig. 5A) in RN
0 , the system initially follows
the third regime (regime N-a) and then regime N (the fourth
Figure 3. Detrimental effect of pathogen avoidance for lethal diseases. It is represented by the difference in life-expectancy between
‘‘normal’’ individuals and ‘‘avoiders’’ (Y-axis; where it is negative, i.e. below the dashed line, avoiding the pathogenic agent is beneficial), according to
the rate of infection by a pathogenic agent (X-axis). (A) For total immune periods of one year, no additional mortality during mild infection and
different values for the case mortality of the classical disease (CM; the total duration of the infection is always 2 weeks); (B) the same as (A) but for
total immune periods of ten years. In both cases avoiding infected individuals is detrimental for high infection rates for case mortalities up to 50%
(and even greater, result not shown), but is always beneficial for diseases without recovery (CM=1, light blue line). (C) Effect of the additional
mortality induced by mild infections, for a case mortality of the classical disease of 10% and total immune periods of one year. For case mortalities of
the mild infection (CMM; the total duration of the mild infection is always 2 weeks) below 5%, avoiding the pathogenic agent is detrimental for high
infection rates. Above 5%, it is always beneficial.
doi:10.1371/journal.pone.0002299.g003
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deleterious. With regard to the duration of immunity, we find the
same effect as previously, i.e. avoiding infections is generally the
best strategy for diseases inducing long immune memory.
Finally, we looked at what happens when we consider larger
coefficients for mild re-infections (q=r=1, Fig. 5B). From a
qualitative perspective we find the same results. However,
quantitatively, the threshold for RN
0 , above which avoiding
infections becomes a deleterious strategy, is largely reduced. Of
course, for RN
0 v10, full avoidance is always the best strategy since
it leads to eradication of the disease. But, for diseases inducing
short-term immunity, as soon as RN
0 is slightly larger than 10, the
‘normal’ strategy becomes the most efficient one. Even when all
individuals avoid the infection, so that the basic reproductive
number of the pathogen is only slightly above 1, the impact of the
disease cannot be reduced below its initial value (when all
individuals are ‘‘normal’’). Another interesting point is that even
for small values of RN
0 (here, for example, for RN
0 ~3) we observe
Figure 4. Impact of pathogen avoidance when the infection rate depends on the number of infected individuals in the population.
We plot here the equilibrium proportion of infected individuals in the host population (Y-axis) according to the proportion of ‘‘avoiders’’ (pA, X-axis).
Note that here the transmission rate of the pathogen can be derived from the value of RN
0 ~3 through the formula b~RN
0
mzazs ðÞ
K . (A) An example of
a situation where the system follows regime A (RN
0 ~10, see Results: Model where exposure depends on infected individuals, for description of
regimes); (B) an example of a situation where the system follows regime A-n (RN
0 ~20); (C) an example of a situation where the system follows regime
N-a (RN
0 ~40) and (D) an example of a situation where the system follows regime N (RN
0 ~80).
doi:10.1371/journal.pone.0002299.g004
Figure 5. Effect of the parameters on the model where the infection rate depends on the number of infected individuals in the
population. (A) Regime followed according to the basic reproductive number of normal individuals (RN
0 ) and duration of immunity (2w{1
N ); (B) same
as (A) but with (q=r=1). The bold lines represent the threshold value at equilibrium, where the number of infected individuals is the same in a
population consisting only of ‘‘avoiders’’ and in a population exclusively composed of ‘‘normal’’ individuals.
doi:10.1371/journal.pone.0002299.g005
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n). This means that even for pathogens with low basic reproductive
numbers, a minimal threshold in the proportion of ‘‘avoiders’’ (pA)
must be attained to make the avoidance strategy beneficial.
Discussion
Reducing pathogen exposure, e.g. by avoiding contact with
infected individuals in the case of directly transmitted diseases or
by avoiding vector bites in the case of vector-borne infections, is an
attractive solution for reducing the impact of diseases. But this
neglects the fact that when the immunity acquired against a
pathogen must be boosted in order to remain efficient, the nature
of the host-pathogen interaction depends on the intensity of
exposure of the host [11]. In such circumstances, reducing
exposure to pathogens provides both beneficial (because it
decreases the probability of developing the severe disease for
susceptible individuals) and detrimental (because it prevents boosts
to immunity) effects. In such cost versus benefit trade-offs,
mathematical models represent useful tools to assess the likelihood
for success of different strategies in different contexts.
Avoiding exposure to the pathogenic agent changes the nature
of the host-pathogen interaction, and can sometimes be a good
strategy. This is the case for pathogens with limited transmissibility
(e.g. sexually transmitted diseases such as gonorrhea), for
pathogens inducing life-long immunity (e.g. measles) and, of
course, for highly lethal diseases (e.g. HIV). The case of poorly
transmissible pathogens can easily extend to all pathogens for
which one may be exposed to a limited number of times during
their lifetime. This is typically the case for travellers’ diarrhoea, a
disease acquired during visits to countries with low hygienic
standards. For a traveller that visits such countries rarely, it is
clearly better to avoid being infected.
In contrast, for highly transmissible pathogenic agents for which
the immune response requires regular boosts to remain efficient,
avoiding infections may be counter-productive and actually
increases the deleterious impact of the pathogenic agent. For
example, in the worst scenario modelled here, ‘‘avoiders’’ were
more than six times more at risk of becoming sick compared to
‘‘normal’’ individuals (see Fig. 2B) or had a life-expectancy
reduced by 30 years (see Fig. 3A). Many pathogenic agents that
induce upper-respiratory tract infections (e.g. the common cold or
influenza) or gastro-enteritis may fall into this category. They are
often highly transmissible and/or induce short-term immunity.
Influenza immunity also, to some extent, wanes gradually with
time. Previous infection by a distinct strain may provide partial
immunity against a new strain [16–18], provided that the
antigenic distance between the two strains is not too high. As
the virus continuously changes, the chance of encountering a
strain that is partly recognized by the immune system decreases
with the time since the previous infection.
Typically, most public health efforts have focused on reducing
the frequency of exposure of individuals to pathogenic agents. This
strategy, despite great successes, has limitations in certain
circumstances. For example, limiting the circulation of a pathogen
may change the age-specific incidence of the infection, sometimes
leading to adverse effects in diseases for which age affects the
clinical outcome of the infection [19–23]. Our work illustrates
another aspect of a general concept that explains these relative
failures. Defense against infections is not only a matter of avoiding
contact with the pathogenic agent, but also of limiting the severity
of infection.
Only an accurate knowledge of the factors influencing the
severity of a disease may help determine if limiting the spread of
the infectious agent is a good strategy. Today, the concept that
regular exposure to pathogenic agents is crucial to maintain
efficient immune defences against infectious diseases is widely
accepted. However, little effort has been made to test this
hypothesis. We believe that the framework we present here
demonstrates that experimental studies must be enacted for
diseases that need to be controlled. Such experiments, coupled
with models like ours, would help with the assessment and design
of control interventions.
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